1 active not recruiting, 1 completed, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
Follow Cortisone: new trials by email Literature Review of Cortisone trials Research Report on Cortisone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Venetoclax Basket Trial for High Risk Hematologic Malignancies Venetoclax, Azacitidine, Cytarabine - Myelodysplastic Syndromes, de Novo, Myelodysplastic Syndromes, Secondary | Phase 1 | Active not recruiting | Andrew E. Place, MD | 14 | 2023-03-29 | 2026-11-18 |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) EZN-3042, Cytarabine, Doxorubicin - Lymphoblastic Leukemia, Acute, Lymphoblastic Leukemia, Acute, Childhood | Phase 1 | Terminated | Therapeutic Advances in Childhood Leukemia Consortium | 6 | 2010-08-24 | 2024-02-01 |
| Is Botox Effective in Relieving Pain From Knee Osteoarthritis? Botulinum toxin type A (Btx-A), Cortisone - Osteoarthritis, Knee | Phase 1 | Completed | Mayo Clinic | 62 | 2005-11-01 | 2012-11-07 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Recurrence (2) · Leukemia (1) · Leukemia, Biphenotypic, Acute (1) · Myelodysplastic Syndromes (1) · Neoplasm Metastasis (1) · Osteoarthritis, Knee (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
Andrew E. Place, MD (1) · Mayo Clinic (1) · Therapeutic Advances in Childhood Leukemia Consortium (1)
United States (3) · Australia (1)
Andrea J. Boon, M.D. (1) · Andrew E Place, MD, PhD (1) · Elizabeth Raetz, MD (1) · William Carroll, MD (1)